Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females

NCT02116361 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02116361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02116361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
April 22, 2014
Completion date
December 22, 2016
Enrollment
258 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major